M S23 (Sotalol AF 80 mg)
Pill imprint M S23 has been identified as Sotalol hydrochloride AF 80 mg.
Sotalol is used in the treatment of atrial fibrillation; ventricular arrhythmia; atrial flutter and belongs to the drug classes group III antiarrhythmics, non-cardioselective beta blockers. There is no proven risk in humans during pregnancy. Sotalol 80 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M S23
- Strength:
- 80 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group III antiarrhythmics
Non-cardioselective beta blockers - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5123
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
More about sotalol
Consumer resources
- Sotalol
- Sotalol oral solution
- Sotalol AF
- Sotalol (Advanced Reading)
- Sotalol Intravenous (Advanced Reading)
- Other brands: Betapace, Sotalol Hydrochloride AF, Sorine, Sotylize, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
